MEDNAX (MD) Reports In-Line Q1 EPS, provides outlook

MEDNAX (NYSE: MD) reported Q1 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $495 million versus the consensus estimate of $500.5 million.

2024 Outlook

As previously disclosed, Pediatrix anticipates that its 2024 Adjusted EBITDA, as defined below, will be in a range of $200 million to $220 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• PB Fintech Limited (POLICYBZ:IN) PT Lowered to INR1,425 at Investec
• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance